TLDR Omalizumab can cause temporary hair loss but still works well for chronic urticaria.
Omalizumab, an anti-IgE medication used for chronic urticaria, was associated with several common adverse effects, including headache and fatigue. Recently, there were reports of hair loss as a side effect. A case was described involving a young female who experienced transient hair loss after starting omalizumab. Despite this, she continued the treatment for 10 months and experienced positive outcomes.
101 citations
,
January 1997 in “Journal of Investigative Dermatology Symposium Proceedings” Nerves and chemicals in the body can affect hair growth and loss.
59 citations
,
June 2022 in “Frontiers in medicine” There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.
1 citations
,
March 2024 in “BioDrugs” Biologics for severe asthma have known side effects, but some new risks need more study.
8 citations
,
October 2021 in “Stem Cell Research & Therapy” Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.
January 2025 in “International Journal of Molecular Sciences” Psoriasis involves immune and genetic factors, and understanding these can improve treatments.
1 citations
,
May 2023 in “Prospects in Pharmaceutical Sciences” New cytokine-targeted therapies show promise for treating alopecia areata.
